Medicare Enrolled
Dr. Wael Elsamman, MD
Internal Medicine · Toms River, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Elsamman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Elsamman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Elsamman
Dr. Wael Elsamman is an internal medicine specialist in Toms River, NJ, with 16 years of NPI registration. Based on federal Medicare data, Dr. Elsamman performed 2,587 Medicare services across 1,981 unique beneficiaries.
Between the years covered by Open Payments, Dr. Elsamman received a total of $18,028 from 57 pharmaceutical and/or device companies across 876 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Elsamman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 16% volume in NJ
$18,028 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,587
Medicare services
Top 16% in NJ for internal medicine
1,981
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~162 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
885 | $65 | $309 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
547 | $66 | $241 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
251 | $139 | $443 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
117 | $102 | $442 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
102 | $33 | $103 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
94 | $72 | $110 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
91 | $65 | $247 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
67 | $104 | $434 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
65 | $35 | $121 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
56 | $16 | $50 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
50 | $10 | $50 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
43 | $3 | $28 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
43 | $179 | $936 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
31 | $281 | $626 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
31 | $33 | $102 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
25 | $24 | $230 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
21 | $21 | $145 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
20 | $97 | $358 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
19 | $49 | $250 |
| Same-day hospital admission and discharge, low complexity Initial hospital care for a patient admitted and discharged on the same day, involving straightforward or low-level medical decision making. The visit requires at least 45 minutes of time if time is used to determine the level of service. |
18 | $75 | $414 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
11 | $27 | $123 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,028
Total received (2018-2024)
Avg $2,575/year across 7 years
Top 4% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
876
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,890 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$138 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,881
2023
$3,245
2022
$2,441
2021
$3,731
2020
$2,385
2019
$3,055
2018
$1,290
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,057
OPKO Pharmaceuticals, LLC
$125
Phathom Pharmaceuticals, Inc.
$114
Abbott Laboratories
$73
Novo Nordisk Inc
$70
ABBVIE INC.
$67
PFIZER INC.
$66
Lilly USA, LLC
$65
Amgen Inc.
$61
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Exact Sciences Corporation
$32
GlaxoSmithKline, LLC.
$30
Bayer Healthcare Pharmaceuticals Inc.
$24
Otsuka America Pharmaceutical, Inc.
$18
UCB, Inc.
$16
Esperion Therapeutics, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 68.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$4,543
Novo Nordisk Inc
$2,605
Lilly USA, LLC
$1,162
GlaxoSmithKline, LLC.
$990
PFIZER INC.
$905
Janssen Pharmaceuticals, Inc
$831
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$821
E.R. Squibb & Sons, L.L.C.
$813
Boehringer Ingelheim Pharmaceuticals, Inc.
$571
ABBVIE INC.
$445
Astellas Pharma US Inc
$433
Amarin Pharma Inc.
$329
Sunovion Pharmaceuticals Inc.
$303
Amgen Inc.
$295
SANOFI-AVENTIS U.S. LLC
$247
Novartis Pharmaceuticals Corporation
$230
Merck Sharp & Dohme Corporation
$215
AbbVie Inc.
$202
Smith+Nephew, Inc.
$185
Abbott Laboratories
$165
Eisai Inc.
$159
OPKO Pharmaceuticals, LLC
$125
Phathom Pharmaceuticals, Inc.
$114
UROVANT SCIENCES INC
$112
Sumitomo Pharma America, Inc.
$109
Genentech USA, Inc.
$109
UCB, Inc.
$105
Paratek Pharmaceuticals, Inc.
$83
Bayer HealthCare Pharmaceuticals Inc.
$81
Exact Sciences Corporation
$76
Esperion Therapeutics, Inc.
$74
Horizon Therapeutics plc
$58
Bausch Health US, LLC
$57
Bayer Healthcare Pharmaceuticals Inc.
$46
SANOFI PASTEUR INC.
$45
Takeda Pharmaceuticals U.S.A., Inc.
$29
Nabriva Therapeutics, plc
$28
EISAI INC.
$26
Aytu BioScience, Inc
$26
Aytu Bioscience, Inc
$26
Dexcom, Inc.
$23
Otsuka America Pharmaceutical, Inc.
$18
Boston Scientific Corporation
$16
Corium, LLC
$16
Teva Pharmaceuticals USA, Inc.
$16
VIVUS LLC
$15
Scilex Pharmaceuticals Inc.
$15
Melinta Therapeutics, Inc.
$15
Merck Sharp & Dohme LLC
$14
Avanir Pharmaceuticals, Inc.
$14
Radius Health, Inc.
$13
Philips Electronics North America Corporation
$13
Medtronic, Inc.
$13
Allergan, Inc.
$12
Horizon Pharma plc
$12
Alexion Pharmaceuticals, Inc.
$12
Sanofi Pasteur Inc.
$11
Top 3 companies account for 46.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIRSUPRA · ANORO ELLIPTA · APLENZIN · APTIOM · AUSTEDO · Adlarity · BAQSIMI · BASAGLAR · BREO · BREZTRI · BREZTRI AEROSPHERE · Baxdela · Briviact · CADUET · CHANTIX · COLLAGENASE SANTYL · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · DUEXIS · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 3 · FreeStyle Libre Pro · Fycompa · GEMTESA · GRAFIX PL · HUMALOG · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LOKELMA · LYRICA · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NUEDEXTA · NURTEC ODT · NUZYRA · Natesto · Neupro · Otezla · Ozempic · PAXLOVID · PENNSAID · PREVNAR 20 · PROCLAIM · QULIPTA · Qsymia · RAYALDEE · RENASYS GO v2 HOME · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · Santyl · Saxenda · Sivextro · Strensiq · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tresiba · Tymlos · UBRELVY · Utibron · VIMOVO · VOQUEZNA · VRAYLAR · Vascepa · Victoza · WATCHMAN · WELLBUTRIN · XARELTO · XIFAXAN · XIFAXANIBSD · Xenleta · Xofluza · Xultophy 100/3.6 · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in NJ.
Geographic Context
Internal medicine physicians within 10 mi
623
Per 100K population
96.4
County median income
$86,411
Nearest hospital
COMMUNITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Elsamman is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NJ), with low-engagement industry engagement in the top 4% of NJ peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Elsamman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Elsamman performed 885 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Elsamman receive payments from pharmaceutical companies?
Yes. Dr. Elsamman received a total of $18,028 from 57 companies across 876 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Elsamman's costs compare to other internal medicine physicians in Toms River?
Dr. Elsamman's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Elsamman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Toms River
Browse internal medicine physicians in Toms River ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology